Investor Information

Aireon Therapeutics has filed Intellectual Property (IP) in the form of patents for single-use, disposable containers pre-filled with ultra-pure water specifically for use in continuous positive airway pressure (CPAP) devices.  Building on this IP, Aireon Therapeutics has also filed patent to use the ultra-pure water as a vehicle for delivering aromatic agents and therapeutic agents via an ad-on device.  The patent filing is available if you contact us.

If you are interested in potential investment opportunities with Aireon Therapeutics the following information can be downloaded: